Close
Help


Forthcoming Articles 24 - 28 September 2012

Posted Thu, Sep, 27,2012

Libertas is pleased to announce that during the week of 24 - 28 September 2012 production commenced for the following articles:

Cell & Tissue Transplantation & Therapy

Immune modulatory responses of Mesenchymal stem cells from different sources in cultures and in vivo

Clinical Medicine Insights: Trauma and Intensive Medicine

Bacterial meningitis and lumbar drainage as a necessary additional treatment

Evolutionary Bioinformatics

A Unifying Mathematical Framework for Genetic Robustness, Environmental Robustness, Network Robustness and their Tradeoff on Phenotype Robustness in Biological Networks Part I: Gene Regulatory Networks in Systems and Evolutionary Biology

Gene Regulation and Systems Biology

Human L-selectin gene is a direct target of Foxo1

Integrative Medicine Insights

To tell or not to tell: Shared decision making, CAM use and disclosure among underserved patients with rheumatic diseases

Substance Abuse: Research and Treatment

Are you sleeping? Pilot comparison of self-reported and objective measures of sleep quality and duration in an inpatient alcoholism treatment program

To receive notifications of new articles immediately upon publication sign up for email alerts

share on
  • Efficient Processing: 4 Weeks Average to First Editorial Decision
  • Fair & Independent Expert Peer Review
  • High Visibility & Extensive Database Coverage
Services for Authors
What Your Colleagues Say About Libertas Academica
This is the fastest progress we have experienced from submission to acceptance.  Reviews are fast, pertinent, and instructive.  Every step of the process is visible and prompt, and every email is friendly and immediate.  In all, it is an excellent experience to be published in Libertas Academica.
Dr Jiang Wang (Sun Yat sen University, Guangzhou, P.R. China.)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube